Our Mission
To improve access to breast cancer recurrence-risk information by offering a faster, lower-cost approach alongside existing pathology workflows
Our Story
As medical research scientists, ‘hope’ as a strategy for cancer care was not an option. Our goal was to make a timely, affordable prognostic test available to clinicians and their patients.
We understand that for patients, the risk of cancer recurrence is one of their greatest fears. For clinicians, the risk of recurrence is one input clinicians consider when planning post-operative care, and recurrence-risk information is one input clinicians weigh within established treatment pathways.
Powered by a team of leading physicists and oncologists, we combined infrared multi-spectral imaging (spectrometry) with a validated multivariate statistical model to generate recurrence-risk information.
We developed a way of reducing the subjectivity inherent in traditional biomarker analysis… In a radically faster way … At a dramatically lower cost.
Thereby creating an opportunity to accelerate informed treatment decision-making and advance cancer patient outcomes.
